Markets:

Overview

News

Currencies

International

Treasuries

Chemours Company (The) Common Stock (NY:CC)

12.70 +0.16 (+1.28%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Chemours Company (The) Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs ↗

November 30, 2025

One hedge fund just made a bold bet on a beaten-down chemicals giant—here’s what long-term investors should know.

Via The Motley Fool

Topics Regulatory Compliance

XRP ETFs Ignite Market with Near-$1 Billion Debut, Signaling Robust Institutional Appetite

November 28, 2025

The cryptocurrency market is buzzing with the highly anticipated debut of several spot XRP Exchange-Traded Funds (ETFs), which have collectively surged towards an impressive $1 billion in assets under...

Via BreakingCrypto

Topics ETFs Economy Regulatory Compliance

Fund Adds $7.2 Million Powell Stake as the Electrical Supplier Posts Record $181 Million Profit ↗

November 23, 2025

One industrial supplier just posted a record year—and a concentrated fund quietly built a new stake.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Where Chemours Stands With Analysts ↗

October 16, 2025

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Chemours Stock ↗

September 23, 2025

Via Benzinga

This Fund Just Took a $5.5 Million Stake in a Turnaround Stock Up 143% This Past Year ↗

November 23, 2025

One fund just made a contrarian bet on an industrial turnaround story—here’s what long-term investors should watch next.

Via The Motley Fool

Top 3 Materials Stocks That Are Preparing To Pump In Q4 ↗

November 07, 2025

Via Benzinga

Chemours (NYSE:CC) Q3 2025 Earnings Miss Estimates, Stock Falls on Weak Guidance ↗

November 06, 2025

Chemours (CC) missed Q3 2025 earnings estimates, with EPS of $0.20 vs. $0.26 expected. Strong Opteon™ sales were offset by weak performance in other segments and a cautious Q4 outlook.

Via Chartmill

Topics Earnings

Investment Company Luminus Loaded Up on This Leading Industrials Stock. Is It a Buy? ↗

October 11, 2025

Via The Motley Fool

Topics Regulatory Compliance

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

A Look at Chemours's Upcoming Earnings Report ↗

August 04, 2025

Via Benzinga

Assessing Chemours: Insights From 8 Financial Analysts ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Luminus Dumps About 43,000 Quaker Chemical Shares Worth $5.6 Million ↗

October 07, 2025

Via The Motley Fool

Topics Regulatory Compliance World Trade

Luminus Trims Its Hefty Chemours Position ↗

October 06, 2025

Via The Motley Fool

Topics Regulatory Compliance

3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending ↗

October 04, 2025

Industrial stocks have started to pick up the pace in terms of price action, yet they are not even close to pricing in the growth potential

Via MarketBeat

Topics Economy Stocks World Trade

Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report ↗

September 15, 2025

Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs.

Via Benzinga

How Do Investors Really Feel About Chemours? ↗

April 22, 2025

Via Benzinga

DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio ↗

August 29, 2025

DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B. Deal aligns with DuPont's strategy to improve profitability and shareholders to benefit from Arclin's...

Via Benzinga

Chemours (CC) Q2 EPS Jumps 53% ↗

August 06, 2025

Via The Motley Fool

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket ↗

July 08, 2025

Via Benzinga

Analyst Expectations For Chemours's Future ↗

July 03, 2025

Via Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields ↗

May 28, 2025

Via Benzinga

6 Analysts Assess Chemours: What You Need To Know ↗

May 07, 2025

Via Benzinga

Chemours Slides After Dividend Cut, Q1 Profit Miss: Retail’s Split As Management Bets On Data Center Cooling ↗

May 07, 2025

The specialty chemicals firm reported a net loss of $4 million, or $0.03 per share, compared with a profit of $54 million, or $0.36 per share, a year earlier.

Via Stocktwits

Topics Artificial Intelligence

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

April 30, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields ↗

April 24, 2025

Via Benzinga

What 6 Analyst Ratings Have To Say About Chemours ↗

April 14, 2025

Via Benzinga

This Check Point Software Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday ↗

March 27, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Chemours Company (The) Common Stock (NY:CC)

Headline News about Chemours Company (The) Common Stock

Starting at $3.75/week.

Subscribe Today